NEAT1 and bone metastasis: Kaplan-Meier survival analysis of Tianjin Medical University data sets showed that high levels of NEAT1–1 or m6A on NEAT1–1 were associated with a shorter survival in prostate cancer patients with bone metastasis and overall survival in primary prostate cancer patients (Fig. 1c and d).